Medicare spending $9B on hepatitis C drugs
WASHINGTON - New government figures show Medicare spending on breakthrough medications for hepatitis C will nearly double this year, passing $9 billion.
That's going to raise insurance costs for all beneficiaries, whether or not they have the liver-wasting disease.
Cost estimates show that Medicare's popular prescription drug program will spend more than $9 billion on hepatitis C drugs this year, a 96 percent increase from $4.7 billion in 2014.
"Hep C" is a viral illness affecting some 3 million people in the U.S. and claims more lives here than AIDS. More than 3 in 4 adults currently infected are baby boomers, the age group now entering Medicare.
New drugs cure the disease, but treatment costs from $80,000 to $100,000. Drug prices are the public's top health care concern in opinion polls.
Desktop NewsClick to open Continuous News in a sidebar that updates in real-time.
Gas restored after vehicle accident damages regulator in Ascension Parish
Deputies arrest alleged Amazon package thief in Ascension Parish
One transported after pedestrian hit on Thomas H. Delpit Drive
Virgina College's Baton Rouge campus to hold las day of classes today
NFL player from Baton Rouge buys out Burlington Coat Factory layaways